METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA

Clinical trials for METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 12 Not yet recruiting 4 Not yet finished but already full! 13 Completed 1 Terminated 1

New hope for pancreatic cancer patients in drug combination trial

Disease control Terminated

This study tested whether adding one or two new drugs (NIS793 and spartalizumab) to standard chemotherapy could better control advanced pancreatic cancer that had spread. It enrolled 164 adults with newly diagnosed metastatic pancreatic cancer who had not received prior treatment…

Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA

Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 02, 2026 15:24 UTC

METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA

Get alerted when new METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA trials appear

New hope for pancreatic cancer patients in drug combination trial